Qin-Yuan Jia

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Zong‐Hao Duan · 8 shared papers, 2022–2025 · strength 1.45
   • Paper TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis. DOI 10.7150/ijbs.104598↗
   • Paper OCIAD2 promotes pancreatic cancer progression through the AKT signaling pathway. DOI 10.1016/j.gene.2024.148735↗
   • Paper The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling path… DOI 10.1186/s12935-024-03440-z↗
2. Yongwei Sun · 8 shared papers, 2022–2025 · strength 1.45
   • Paper TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis. DOI 10.7150/ijbs.104598↗
   • Paper OCIAD2 promotes pancreatic cancer progression through the AKT signaling pathway. DOI 10.1016/j.gene.2024.148735↗
   • Paper The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling path… DOI 10.1186/s12935-024-03440-z↗
3. Hong‐Fei Yao · 8 shared papers, 2022–2025 · strength 1.43
   • Paper TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis. DOI 10.7150/ijbs.104598↗
   • Paper OCIAD2 promotes pancreatic cancer progression through the AKT signaling pathway. DOI 10.1016/j.gene.2024.148735↗
   • Paper The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling path… DOI 10.1186/s12935-024-03440-z↗
4. Yan‐Miao Huo · 7 shared papers, 2023–2025 · strength 1.26
   • Paper TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis. DOI 10.7150/ijbs.104598↗
   • Paper The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling path… DOI 10.1186/s12935-024-03440-z↗
   • Paper Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment. DOI 10.1007/s13402-022-00741-1↗
5. Yu-Heng Zhu · 7 shared papers, 2022–2025 · strength 1.25
   • Paper TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis. DOI 10.7150/ijbs.104598↗
   • Paper OCIAD2 promotes pancreatic cancer progression through the AKT signaling pathway. DOI 10.1016/j.gene.2024.148735↗
   • Paper The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling path… DOI 10.1186/s12935-024-03440-z↗
6. Jia-Hao Zheng · 7 shared papers, 2023–2024 · strength 1.24
   • Paper OCIAD2 promotes pancreatic cancer progression through the AKT signaling pathway. DOI 10.1016/j.gene.2024.148735↗
   • Paper The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling path… DOI 10.1186/s12935-024-03440-z↗
   • Paper Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment. DOI 10.1007/s13402-022-00741-1↗
7. Yifan Yin · 4 shared papers, 2024 · strength 0.73
   • Paper OCIAD2 promotes pancreatic cancer progression through the AKT signaling pathway. DOI 10.1016/j.gene.2024.148735↗
   • Paper A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer. DOI 10.1016/j.celrep.2024.114633↗
   • Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w↗
8. Minwei Yang · 4 shared papers, 2023–2025 · strength 0.73
   • Paper TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis. DOI 10.7150/ijbs.104598↗
   • Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w↗
   • Paper AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progressio… DOI 10.1016/j.canlet.2024.217130↗
9. Shu‐Heng Jiang · 3 shared papers, 2023–2024 · strength 0.53
   • Paper Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment. DOI 10.1007/s13402-022-00741-1↗
   • Paper A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer. DOI 10.1016/j.celrep.2024.114633↗
   • Paper AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progressio… DOI 10.1016/j.canlet.2024.217130↗
10. Dejun Liu · 3 shared papers, 2022–2024 · strength 0.49
    • Paper Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment. DOI 10.1007/s13402-022-00741-1↗
    • Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w↗
    • Paper Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarci… DOI 10.3390/ph15111336↗
11. Jian‐Yu Yang · 3 shared papers, 2022–2024 · strength 0.47
    • Paper The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling path… DOI 10.1186/s12935-024-03440-z↗
    • Paper Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreat… DOI 10.1007/s10495-023-01843-3↗
    • Paper Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarci… DOI 10.3390/ph15111336↗
12. Jian Yang · 3 shared papers, 2022–2024 · strength 0.47
    • Paper A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer. DOI 10.1016/j.celrep.2024.114633↗
    • Paper Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreat… DOI 10.1007/s10495-023-01843-3↗
    • Paper Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarci… DOI 10.3390/ph15111336↗
13. Yifan Yin · 2 shared papers, 2024–2025 · strength 0.40
    • Paper TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis. DOI 10.7150/ijbs.104598↗
    • Paper The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling path… DOI 10.1186/s12935-024-03440-z↗
14. Rong Hua · 2 shared papers, 2024 · strength 0.36
    • Paper The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling path… DOI 10.1186/s12935-024-03440-z↗
    • Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w↗
15. Wei Liu · 2 shared papers, 2024 · strength 0.35
    • Paper A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer. DOI 10.1016/j.celrep.2024.114633↗
    • Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w↗
16. Li-Peng Hu · 2 shared papers, 2024 · strength 0.35
    • Paper A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer. DOI 10.1016/j.celrep.2024.114633↗
    • Paper AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progressio… DOI 10.1016/j.canlet.2024.217130↗
17. Dejun Liu · 2 shared papers, 2024 · strength 0.35
    • Paper A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer. DOI 10.1016/j.celrep.2024.114633↗
    • Paper AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progressio… DOI 10.1016/j.canlet.2024.217130↗
18. Xueliang Fu · 2 shared papers, 2023–2024 · strength 0.33
    • Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w↗
    • Paper Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreat… DOI 10.1007/s10495-023-01843-3↗
19. Pei‐Xuan Ji · 2 shared papers, 2022–2024 · strength 0.31
    • Paper A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer. DOI 10.1016/j.celrep.2024.114633↗
    • Paper Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarci… DOI 10.3390/ph15111336↗
20. Wei Liu · 1 shared paper, 2025 · strength 0.22
    • Paper TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axis. DOI 10.7150/ijbs.104598↗
21. Wei Liu · 1 shared paper, 2024 · strength 0.20
    • Paper OCIAD2 promotes pancreatic cancer progression through the AKT signaling pathway. DOI 10.1016/j.gene.2024.148735↗
22. Wei Liu · 1 shared paper, 2024 · strength 0.18
    • Paper The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling path… DOI 10.1186/s12935-024-03440-z↗
23. Junfeng Zhang · 1 shared paper, 2024 · strength 0.18
    • Paper The lncRNA LINC01605 promotes the progression of pancreatic ductal adenocarcinoma by activating the mTOR signaling path… DOI 10.1186/s12935-024-03440-z↗
24. Jianyu Yang · 1 shared paper, 2024 · strength 0.18
    • Paper Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarci… DOI 10.1038/s41419-024-07110-w↗
25. Qing Li · 1 shared paper, 2024 · strength 0.18
    • Paper A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer. DOI 10.1016/j.celrep.2024.114633↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.